ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,659Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 2343

$1.42M Total Retail Price of All Prescriptions

Rank: 30 out of 2343

741 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 741 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 741 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 23,966 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OMEPRAZOLE 1,347 1,200 1 4
AMLODIPINE BESYLATE 1,266 1,192 2 5
LISINOPRIL 1,128 1,022 3 3
ATENOLOL 1,117 1,047 4 12
PRAVASTATIN SODIUM 1,038 904 5 15
LEVOTHYROXINE SODIUM 898 776 6 2
FUROSEMIDE 823 725 7 6
METOPROLOL TARTRATE 738 690 8 7
METFORMIN HCL 591 485 9 9
ATORVASTATIN CALCIUM 518 482 10 10
METOPROLOL SUCCINATE 515 471 11 14
JANTOVEN 429 421 12 81
KLOR-CON 8 421 371 10 13 226
WARFARIN SODIUM 398 393 14 8
SIMVASTATIN 340 301 15 1
HYDROCHLOROTHIAZIDE 304 285 16 11
LOVASTATIN 291 265 17 47
DONEPEZIL HCL 287 287 18 21
SERTRALINE HCL 271 233 19 20
PREDNISONE 271 234 19 37
GABAPENTIN 265 190 21 16
OXYCODONE-ACETAMINOPHEN 261 125 S2 22 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 256 217 23 42
FAMOTIDINE 251 208 24 60
CRESTOR 249 220 25 30
GLIPIZIDE 249 163 25 56
DIOVAN 237 231 27 23
POTASSIUM CHLORIDE 236 204 28 18
DOXAZOSIN MESYLATE 232 206 29 98
ISOSORBIDE MONONITRATE ER 229 227 30 32
CLOPIDOGREL 223 201 31 26
DILTIAZEM 24HR ER 223 220 31 76
ALENDRONATE SODIUM 215 214 33 28
FLUOXETINE HCL 198 134 34 82
GLIPIZIDE XL 173 155 35 84
PANTOPRAZOLE SODIUM 171 152 36 22
ADVAIR DISKUS 169 139 37 34
LIPITOR 168 165 38 78
ALLOPURINOL 167 144 39 31
DIGOXIN 164 152 40 35
NAMENDA 162 162 41 36
PROCRIT 161 161 42 306
CLOTRIMAZOLE-BETAMETHASONE 153 138 43 127
MIRTAZAPINE 146 145 44 41
PLAVIX 145 132 45 38
TRAMADOL HCL 141 65 46 25
AMOX TR-POTASSIUM CLAVULANATE 138 114 47 160
TRIAMCINOLONE ACETONIDE 138 121 47 137
ZETIA 133 124 49 52
FLUTICASONE PROPIONATE 132 125 50 46
AZITHROMYCIN 123 93 51 39
CITALOPRAM HBR 121 84 52 17
GLIPIZIDE ER 120 115 53 115
LOSARTAN POTASSIUM 119 113 54 19
KLOR-CON M20 117 104 55 44
LEVOFLOXACIN 115 89 56 106
CEPHALEXIN 110 106 57 111
LANTUS 109 84 58 51
DICLOFENAC POTASSIUM 105 92 59 447
JANUVIA 105 82 59 50
TAMSULOSIN HCL 104 103 61 29
FINASTERIDE 103 91 62 80
FENTANYL 100 86 S2 63 69
PEN NEEDLE 99 81 64 119
ZOLPIDEM TARTRATE 95 78 65 24
NEXIUM 94 67 66 33
SINGULAIR 94 79 66 100
SPIRIVA 93 81 68 48
COLCRYS 92 80 69 166
MELOXICAM 90 76 70 68
TRIAMTERENE-HCTZ 89 70 71 57
TRAZODONE HCL 88 54 72 53
VERAPAMIL ER 87 74 73 95
CARBIDOPA-LEVODOPA 87 81 73 85
TRICOR 86 51 75 96
DIOVAN HCT 85 63 76 63
NITROGLYCERIN PATCH 84 84 77 147
PAROXETINE HCL 84 50 77 66
DILTIAZEM 24HR CD 83 81 79 83
PROAIR HFA 81 60 80 86
NITROSTAT 78 71 81 164
HYDROCODONE-ACETAMINOPHEN 77 62 S3 82 13
CARVEDILOL 76 59 83 27
OXYCONTIN 73 46 S2 84 138
INSULIN SYRINGE 73 64 84 102
KLOR-CON M10 73 60 84 107
POLYETHYLENE GLYCOL 3350 73 73 84 54
FELODIPINE ER 73 73 84 116
COMBIVENT 69 56 89 144
CIPROFLOXACIN HCL 68 59 90 72
OXYCODONE HCL-ACETAMINOPHEN 68 31 S2 90 136
CARTIA XT 68 62 90 432
NORTRIPTYLINE HCL 68 54 90 239
RANITIDINE HCL 68 55 90 43
ABILIFY 64 39 95 159
LANSOPRAZOLE 63 50 96 162
GEMFIBROZIL 62 50 97 133
ACETAMINOPHEN-CODEINE 61 60 S3 98 112
OXYBUTYNIN CHLORIDE ER 61 41 98 149
LORAZEPAM 60 60 100 210
RIVASTIGMINE 59 48 101 395
RISPERIDONE 59 39 101 61
SYMBICORT 59 33 101 167
MECLIZINE HCL 59 54 101 103
DILTIAZEM ER 57 57 105 207
PHENYTOIN SODIUM EXTENDED 56 50 106 152
TERAZOSIN HCL 56 56 106 143
TAMIFLU 56 50 106 322
VENLAFAXINE HCL ER 56 40 106 87
CELEBREX 55 55 110 71
METOLAZONE 54 48 111 173
GLYBURIDE 54 54 R 111 62
OXYCODONE HCL 53 32 S2 113 67
NAPROXEN 52 31 114 108
MUPIROCIN 51 0 115 260
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.